Semaglutide Definition: What Semaglutide Is and How It Works

Semaglutide is a prescription GLP-1 receptor agonist that mimics a natural gut hormone to lower blood sugar, slow digestion, and reduce appetite. In the United States it is FDA-approved under brand names including Ozempic, Wegovy, and Rybelsus for type 2 diabetes and chronic weight management. It is not a fat-burning supplement, and it is not legally available without a prescription.

What Is Semaglutide? A Plain-English Definition

Semaglutide belongs to a drug class called GLP-1 receptor agonists, also known as incretin mimetics. The name comes from glucagon-like peptide-1, a hormone your gut releases after you eat. A GLP-1 drug copies that hormone's message: food has arrived, so release insulin and stop eating.

Semaglutide is a synthetic analog, meaning its structure was engineered to act like human GLP-1 while lasting far longer in the bloodstream. That engineering is why it can be injected once a week instead of being continuously infused.

What Is In Semaglutide? The Chemical Structure

Semaglutide is a 31-amino-acid peptide with a molecular weight of roughly 4,113.6 g/mol. Its backbone is about 94% identical to native human GLP-1. Two modifications do most of the work:

• A substitution at position 8, where alpha-aminoisobutyric acid replaces alanine, which blocks the enzyme DPP-4 from breaking the peptide down.
• A fatty diacid side chain attached through a linker, which binds albumin in the blood and releases the drug slowly.

The result is a half-life of about one week, or roughly 165 hours, compared with one to two minutes for the natural hormone. That single change is the heart of semaglutide pharmacology.

How Semaglutide Works in the Body

Semaglutide activates GLP-1 receptors in three main places, and each one contributes to its effects.

• Pancreas: boosts insulin release when glucose is high and suppresses glucagon, the hormone that raises blood sugar.
• Brain: acts on appetite-regulating centers in the hypothalamus and brainstem, increasing fullness and quieting hunger cues.
• Stomach and gut: slows gastric emptying, so food leaves the stomach more slowly and meals feel more satisfying.

The appetite effect is the main reason semaglutide treats obesity. People eat less because they feel full sooner and stay full longer, not because the drug speeds up metabolism.

Does Semaglutide Burn Fat?

Semaglutide does not directly burn fat. It does not raise resting metabolic rate, and it does not destroy fat cells.

Instead, semaglutide reduces calorie intake, and the resulting energy deficit drives fat loss. Clinical trials of Wegovy showed average weight reductions of about 15% over 68 weeks when the drug was combined with diet and exercise, but the mechanism is appetite suppression rather than thermogenesis.

That distinction matters for anyone comparing semaglutide with compounds marketed as fat burners. Some research does explore direct GLP-1 effects on fat tissue, but the dominant and well-documented action is simply eating less.

Semaglutide Uses and Approved Indications

Semaglutide used for diabetes and semaglutide used for weight management are different products with different dosing. The table below summarizes the FDA-approved options sold in the US.

Brand Name	Form	Approved Indication	Typical Maintenance Dose
Ozempic	Weekly injection	Type 2 diabetes	0.5 mg to 2 mg weekly
Wegovy	Weekly injection	Chronic weight management	2.4 mg weekly
Rybelsus	Daily oral tablet	Type 2 diabetes	7 mg or 14 mg daily

Doses escalate over several weeks to limit gastrointestinal side effects. Wegovy is intended for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes.

Compounded semaglutide sold online is not FDA-approved, and the agency has warned about dosing errors and unverified ingredients in some of those products.

Semaglutide Options and Comparisons

Semaglutide is no longer the only GLP-1 option on the market. Search interest in retatrutide vs tirzepatide vs semaglutide reflects how quickly the field is expanding, and the answer depends entirely on the endpoint being measured. In the SURMOUNT-5 trial, tirzepatide produced greater average weight loss than semaglutide, while semaglutide has the longest safety record of the three.

Combination research is also active. Trials have tested cagrilintide and semaglutide together, pairing a GLP-1 agonist with an amylin analog to see whether the combination outperforms either drug alone. Reports from those studies describe a cagrilintide semaglutide dosage that escalates gradually, similar to standard GLP-1 titration.

Other pairings are less direct. Blends marketed as semaglutide l carnitine combine a GLP-1 agonist with an amino acid often promoted for fat metabolism, though carnitine's added benefit has not been established in large trials. In research settings, aod 9604 and semaglutide are discussed in the same fat-loss conversations even though the two compounds act through entirely different pathways.

Safety, Side Effects, and Key Cautions

Semaglutide is generally well tolerated, but side effects are common, especially during dose increases.

• Nausea, vomiting, diarrhea, constipation, and abdominal pain are the most frequent complaints.
• Serious but rare risks include pancreatitis, gallbladder disease, and kidney injury caused by dehydration.
• Boxed warnings cover thyroid C-cell tumors seen in rodents and a risk of low blood sugar when the drug is combined with insulin or sulfonylureas.
• Semaglutide is not recommended during pregnancy and is contraindicated in people with a personal or family history of medullary thyroid cancer or MEN2.

Rapid weight loss can also reduce lean muscle mass, which is why adequate protein intake and resistance training are commonly recommended alongside treatment. Anyone wondering whether semaglutide is appropriate for them should speak with a licensed healthcare professional rather than relying on online summaries.

Semaglutide is a prescription medication in the United States, and it is not a cure for obesity or diabetes. It is a tool that works best alongside nutrition, physical activity, and ongoing medical supervision.

COMMON QUESTIONS

Frequently Asked Questions

Is semaglutide the same as Ozempic?

Ozempic is one brand name for semaglutide, approved for type 2 diabetes. Wegovy and Rybelsus contain the same active ingredient but are approved for different uses and different doses. All three are prescription-only in the United States.

Does semaglutide burn fat?

No. Semaglutide does not burn fat directly or raise metabolism; it reduces appetite and calorie intake, which leads to fat loss over time. The weight loss seen in clinical trials came from that calorie deficit combined with diet and exercise.

How long does semaglutide stay in your system?

Semaglutide has a half-life of about one week, so it takes roughly four to five weeks to clear after the last dose. That long half-life is why it is dosed weekly and why side effects can linger for a while after stopping.